News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Laliberte Kevin
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2019 |
4
| Laliberte Kevin (Sr. VP, Product Development) has filed a Form 4 on Dova Pharmaceuticals Inc.|
Txns:
| Sold 3,100 shares
@ $20, valued at
$62k
|
|
| 08/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2019 |
4
| Laliberte Kevin (Sr. VP, Product Development) has filed a Form 4 on Dova Pharmaceuticals Inc.|
Txns:
| Granted 7,937 shares
@ $0
Granted 50,000 options to buy
@ $8.82, valued at
$441k
|
|
| 03/14/2018 |
4
| Laliberte Kevin (Sr. VP, Product Development) has filed a Form 4 on Dova Pharmaceuticals, Inc.|
Txns:
| Granted 50,000 options to buy
@ $29.33, valued at
$1.5M
|
|
| 11/08/2017 |
4
| Laliberte Kevin (Sr. VP, Product Development) has filed a Form 4 on Dova Pharmaceuticals, Inc.|
Txns:
| Granted 24,750 options to buy
@ $0 |
|
| 07/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/28/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|